Post by
DJDawg on May 30, 2023 11:14pm
Good clinical update
I'm happy with the swimmers plot data and the continued improvements in CR%.
What I am not skilled at is interpreting the financial situation. Can anyone with a finance background weigh in? I can't see how they would have much more than a few dollars left.
Comment by
Yajne on May 31, 2023 12:05am
Agreed DJDawg. I'm no accountant but I just see "cash and cash equivalents of $365K as of March31" If so, and with two months gone since March31, I'm guessing that theyre running fairly tight on cash at the moment. Could a monumental NR be in the wings that would put warrants in the money?
Comment by
Yajne on May 31, 2023 12:40am
Further, in the MD&A the section "Going Concern, Capital Disclosures and Statement of Compliance" includes this line which I believe it was also included in the April MD&A: The Company is currently seeking new financing opportunities and intends to complete a financing round in Q2 2023.
Comment by
Oilminerdeluxe on May 31, 2023 1:05am
Financing within a month then. Good to have it over and done with. Onwards.
Comment by
Oilminerdeluxe on May 31, 2023 3:22am
I seem to recall a video with Dr. Kulkarni where he said 30% would be *phenomenal" results. So 33% is better than phenomenal.
Comment by
Alamir1111 on May 31, 2023 7:42am
So they filed the financial. On a 1.4 million expence you get to claim13% hst +gst which comes to around 180000$. Plus the 300000 +in the piggy ithink they good till early august
Comment by
Sunvalley on May 31, 2023 9:08am
Just enough cash until the FDA approval kicks in if everything goes tickety-boo and if the application is filed immediatly. Then big pharma makes a deal with TLT with the necessary cash consideration up front and we are away to the races. We shall see how good RDW is at threading the needle from this point onwards. Possible but only a news release would confirm the foregoing.